Search by Drug Name or NDC

    NDC 65162-0254-10 Ranitidine 300 mg/1 Details

    Ranitidine 300 mg/1

    Ranitidine is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Amneal Pharmaceuticals LLC. The primary component is RANITIDINE HYDROCHLORIDE.

    Product Information

    NDC 65162-0254
    Product ID 65162-254_3f730b87-2405-485e-a562-ff56320cac69
    Associated GPIs 49200020100310
    GCN Sequence Number 011674
    GCN Sequence Number Description ranitidine HCl TABLET 300 MG ORAL
    HIC3 Z2D
    HIC3 Description HISTAMINE H2-RECEPTOR INHIBITORS
    GCN 10201
    HICL Sequence Number 004520
    HICL Sequence Number Description RANITIDINE HCL
    Brand/Generic Generic
    Proprietary Name Ranitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Ranitidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name RANITIDINE HYDROCHLORIDE
    Labeler Name Amneal Pharmaceuticals LLC
    Pharmaceutical Class Histamine H2 Receptor Antagonists [MoA], Histamine-2 Receptor Antagonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA077824
    Listing Certified Through 2024-12-31

    Package

    NDC 65162-0254-10 (65162025410)

    NDC Package Code 65162-254-10
    Billing NDC 65162025410
    Package 100 TABLET in 1 BOTTLE (65162-254-10)
    Marketing Start Date 2009-12-16
    NDC Exclude Flag N
    Pricing Information N/A